Nevro Q1 2024 GAAP EPS $(0.70) Beats $(1.08) Estimate, Sales $101.899M Beat $97.892M Estimate
Portfolio Pulse from Benzinga Newsdesk
Nevro (NYSE:NVRO) reported Q1 2024 earnings with a GAAP EPS of $(0.70), surpassing the $(1.08) estimate, and sales of $101.899M, exceeding the $97.892M estimate. This represents a 28.57% improvement in EPS and a 5.78% increase in sales compared to the same period last year.
May 07, 2024 | 8:59 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Nevro reported a significant beat on both EPS and sales estimates for Q1 2024, indicating strong financial performance and potential growth.
Beating EPS and sales estimates by a significant margin suggests operational efficiency and market demand for Nevro's products. This positive earnings report is likely to instill investor confidence, potentially leading to a short-term uptick in NVRO's stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100